Apellis Pharmaceuticals Inc (NASDAQ:APLS)

42.65
Delayed Data
As of May 27
 +0.70 / +1.67%
Today’s Change
27.50
Today|||52-Week Range
73.00
-9.79%
Year-to-Date
No recent news for Apellis Pharmaceuticals Inc.

Today’s Trading

Previous close41.95
Today’s open41.78
Day’s range41.28 - 43.24
Volume56,075
Average volume (3 months)1,127,127
Market cap$4.8B
Data as of 4:10pm ET, 05/27/2022

Growth & Valuation

Earnings growth (last year)-92.68%
Earnings growth (this year)+36.97%
Earnings growth (next 5 years)+19.28%
Revenue growth (last year)-73.44%
P/E ratioNM
Price/Sales59.96
Price/Book22.00

Competitors

----
----
EVOEvotec SE+0.36+2.66%
ALKSAlkermes Plc+1.16+3.95%
Data as of 4:00pm ET, 05/27/2022

Financials

Next reporting dateAugust 4, 2022
EPS forecast (this quarter)-$1.29
Annual revenue (last year)$66.6M
Annual profit (last year)-$746.4M
Net profit margin-1,121.27%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
No executives to display
Corporate headquarters
Waltham, Massachusetts

Forecasts